Accès direct au contenu


Version française > Publications > Publications 2015

Publications 2015

Kienana M1, Lydie ND, Jean-Michel H, Binta D, Matthias B, Patrick E, Hélène B, Chantal le G. Elucidating time-dependent changes in the urinary metabolome of renal transplant patients by a combined (1)H NMR and GC-MS approach. Mol Biosyst. 2015 Sep 11


S. Chadet, F. Ivanes, L. Benoist, C. Salmon-Gandonnière, R. Guibon, F. Velge-Roussel, D. Babuty, C. Baron, S. Roger, D. Angoulvant. Hypoxia/Reoxygenation Inhibits P2Y11 Receptor Expression and Its Immunosuppressive Activity in Human Dendritic Cells. J Immunol. 2015 Jun 15. pii: 1500197.

N. Mewton, T. T Cung, O. Morel, G. Cayla, E. Bonnefoy-Cudraz, G. Rioufol, D. Angoulvant, P. Guerin, M. Elbaz, N. Delarche, [...], P. Staat, A. Sudre, M. J Hansson, E. Elmer, I. Boussaha, C. Jossan, A. Torner, M. Claeys, D. Garcia-Dorado, M. Ovize. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial). American heart journal 06/2015; 169(6):758-766.e6.

R. Philippart, A. Brunet-Bernard, N. Clementy, T. Bourguignon, A. Mirza, D. Babuty, D. Angoulvant, G. Y H Lip, L. Fauchier. Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. European Heart Journal 05/2015

A. Bernard, X. Bailleul, F. Ivanes, F. Dion, C. Saint-Etienne, G. Pacouret, L. Quilliet, B. Desveaux, D. Angoulvant. 37 Detection of ischemia by multilayer strain at the acute phase of a myocardial infarction. Archives of Cardiovascular Diseases Supplements 05/2015

Y. Ancedy, C. Saint Etienne, F. Ivanes, A. Bernard, D. Babuty, D. Angoulvant, L. Fauchier. 0018 : Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: An assessment of the ESC guidelines adherence. Archives of Cardiovascular Diseases Supplements 04/2015; 7(2):135.

E. Siméon, A. Bernard, N. Clémenty, G. Herault, W. El-Hage, C. Monpère, F. Ivanés, T. Angoulvant, D. Babuty. Severe recurrent vasovagal syncope and multidisciplinary rehabilitation: A prospective randomized pilot study. International journal of cardiology 04/2015; 187:658-659.

A. Thollet, P. Mabo, D. Babuty, J. Mansourati, J.M. Davy, B. Petit, S. Bézieau, F. Sacher, S. Le Scouarnec, J.J. Schott, H. Le Marec, V. Probst, J.B. Gourraud, F. Kyndt. 0186 : Genotype/phenotype relationship in a large cohort of long QT syndrome patients. Archives of Cardiovascular Diseases Supplements 04/2015; 7(2):171

D. Angoulvant, T. Bejan Angoulvant, L. Fauchier. Dual antiplatelet therapy after acute coronary syndrome: a cardiologist-based optimal decision. Heart (British Cardiac Society) 04/2015; 101(11).

D. Therasse, F. Simonet, C. Dina, A. Thollet, P. Mabo, F. Sacher, D. Babuty, P. Maury, J.J. Schott, H. Le Marec, R. Redon, V. Probst, J.B. Gourraud. 0210 : Effect of SCN5A mutations and SCN10A, SCN5A and HEY2 frequent variants on ECG of Brugada patients during ajmaline test. Archives of Cardiovascular Diseases Supplements 04/2015;

A. Vaduva, R. Lighezan, O. Duicu, A. Sturza, H. Feier, M. Gaspar, D. Angoulvant, C. Mornos, D. M. Muntean. 0434 : Evaluation of ROS generation and mitochondrial respiration in atrial samples from diabetic and non-diabetic coronary patients. Archives of Cardiovascular Diseases Supplements 04/2015; 7(2).

S. Le Page, T. Bejan-Angoulvant, D. Angoulvant, F. Prunier. Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Archiv für Kreislaufforschung 03/2015; 110(2):467.

L. Fauchier, D. Angoulvant, G. Y H Lip. The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. Europace 03/2015; 17(5). DOI:10.1093/europace/euv088

B. Fiquet, D. Joly, J.-M. Halimi, G. Choukroun, C. Combe, B. Dussol, J.-P. Fauvel, S. Quéré. P232 Contrôle de la pression artérielle et de la protéinurie chez des diabétiques de type 2 protéinuriques : résultats finaux de la cohorte ALICE-PROTECT. Diabetes & Metabolism 03/2015; 41:A92.

B. Fiquet, J.-P. Fauvel, D. Joly, C. Combe, G. Choukroun, J.-M. Halimi, B. Dussol, S. Quéré. O70 Déclin du eDFG des diabétiques de type 2 protéinuriques: étude ALICE-PROTECT. Diabetes & Metabolism 03/2015; 41:A20.

M. Hallab, J.-M. Halimi, S. Bertin. P289 La vitesse de l’onde de pouls avec pOpmètre® est indépendamment corrélée au taux de filtration glomérulaire chez les transplantés rénaux. Diabetes & Metabolism 03/2015; 41:A106.

M. Monseu, E. Gand, P.-J. Saulnier, D. Montaigne, P. Zaoui, V. Rigalleau, G. Ducroq, R. Roussel, C. Hulin, P. Sosner, P. Llaty, S. Ragot, S. Hadjadj, J.-M. Halimi. O69 Les marqueurs rénaux utilisés conjointement sont des marqueurs de risques cardiovasculaire et non cardiovasculaire majeurs chez les diabétiques de type 2. Diabetes & Metabolism 03/2015; 41:A19-A20.

L. Pericart, A.B. Bernard, L. Bernard, D. Babuty, D. Angoulvant, A. Mirza, L. Fauchier. 0189: Identification of risk factors for embolic events in left-sided infective endocarditis. Archives of Cardiovascular Diseases Supplements 01/2015; 7(1):47.

J. Noble, M. Buechler, C. Forconi, R. Guibon, Y. Lebranchu, J. M. Halimi, C. Baron, P. Gatault. Transplantation of kidney with cytomegalovirus (CMV) seropositive donors durably affects the long term anti-CMV response in recipients. Transplant International 28:13-14 · January 2015

Y. Lebranchu, C. Legendre, P. Merville, A. Durrbach, L. Rostaing, G. Thibault, G. Paintaud, S. Quere, F. D. Giambattista, M. Buchler . Comparison of interleukin-2 blockade in kidney transplant patients randomized to 40 or 80 mg Basiliximab with Cyclosporine or 80 mg Basiliximab with Everolimus. Transplant International 01/2015; 28:11-11

J.-M. Halimi. Inhibiteurs du SGLT2 : mécanisme d’action, effets rénaux et effets sur la pression artérielle. Médecine des Maladies Métaboliques 01/2015; 9(1):S26-S29.

E. Bailly, A. Assaqa, P. Gatault, V. Chabot, Y. Lebranchu, J. M. Halimi, C. Baron, M. Buechler. Anti-HLA antibodies and human dendritic cell: in vitro effects on cell maturation and survival. Transplant International 01/2015; 28:11-11

J. Noble, P. Gatault, C. Barbet, H. Longuet, E. Bailly, L. B. Lakshmi, C. Gaudy-Graffin, C. Baron, J. -M. Halimi, Y. Lebranchu, M. Buchler. Pronostic value of low PCR Cytomegalovirus load in kidney transplant recipients. Transplant International 01/2015; 28:13-13

A. Bouzeman, E. Marijon, P. Defaye, O. Piot, C. Leclercq, N. Sadoul, D. Gras, D. Klug, V. Algalarrondo, P. Bordachar, J.C. Deharo, D. Babuty, S. Boveda. 0388: Natural history of primary prevention implantable cardioverter defibrillators: results of a French multi-centric registry. Archives of Cardiovascular Diseases Supplements 01/2015; 7(1):60.

S. Mahida, N. Derval, F. Sacher, A. Leenhardt, I. Deisenhofer, D. Babuty, J. Schläpfer, L. de Roy, R. Frank, S. Yli-Mayry, [...], S. Yamashita, L. Roten, H. S Lim, A. Denis, P. Bordachar, P. Ritter, V. Probst, M. Hocini, P. Jaïs, M. Haïssaguerre. Role of Electrophysiological Studies in Predicting Risk of Ventricular Arrhythmia in Early Repolarization Syndrome. Journal of the American College of Cardiology 01/2015; 65(2):151-9.

Y. Le Meur, M. Buechler, C. Mousson, M. C. Moal, L. Albano, P. Merville, S. Caillard, I. Etienne, M. Hazzan, D. Anglicheau, J. P. Rerolle, A. E. Heng, A. E. Thierry, C. Vignaud, O. Toupance, V. Chatelet, H. Mazouz, G. Mourad, N. Kamar. Everold: a multicenter randomized study for the use of Everolimus in “old-for-old” renal transplantation. Transplant International 01/2015; 28:8-8.


  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

Retour au site institutionnel